{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:38:32Z","timestamp":1777289912101,"version":"3.51.4"},"reference-count":81,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","award":["88887.140222\/2025-00"],"award-info":[{"award-number":["88887.140222\/2025-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"abstract":"<jats:p>Bladder cancer (BCa) is a histologically and molecularly heterogeneous disease and is one of the leading causes of cancer death globally. The main risk factors are sex (with incidence 3 to 4 times higher in men), tobacco usage, occupational exposure to carcinogens, and persistent infections, such as those caused by Schistosoma haematobium. Urine and the bladder were recently confirmed to be non-sterile, prompting investigations into the urinary and intratumoral microbiomes and their roles in tumor stage, prognosis, and therapy response. In this context, the role of the urinary and intratumoral microbiome in bladder carcinoma is among the most promising areas in translational uro-oncology. Recent evidence demonstrates the presence and diversity of microbial communities in both urine and bladder cancer tissue, with patterns associated with tumor stage and prognosis. Chronic inflammation, genotoxin production, altered carcinogen metabolism, and modulation of the immune microenvironment are biological processes that provide a rationale for the functional role of these microorganisms in the bladder. Furthermore, microbial profiles have been correlated with responses to intravesical therapies (such as BCG - Bacillus Calmette-Gu\u00e9rin) and, potentially, with systemic immunotherapies. The microbiome can help identify predictors of treatment response and potential adjuvant interventions, and offers a non-invasive, translational pathway for diagnosis and surveillance. This review summarizes current evidence on the microbiome in bladder cancer patients and its prognostic and therapeutic potential.<\/jats:p>","DOI":"10.1590\/1414-431x2026e15526","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:51:56Z","timestamp":1777287116000},"source":"Crossref","is-referenced-by-count":0,"title":["The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response"],"prefix":"10.1590","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5501-1872","authenticated-orcid":false,"given":"J.","family":"C\u00f4rtes","sequence":"first","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil; Instituto de Bioci\u00eancias, Universidade Estadual Paulista,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-1339","authenticated-orcid":false,"given":"J.C.S.","family":"Trindade Filho","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-5687","authenticated-orcid":false,"given":"S.R.","family":"Rogatto","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil; University Hospital of Southern Denmark,  Denmark; University of Southern Denmark,  Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"3","key":"ref1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"ref2","first-page":"10454","article-title":"Young population bladder neoplasms","volume":"27","author":"\u00c7ivi \u00c7etin K","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"23","key":"ref3","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.3390\/cancers16234100","article-title":"Sex disparities in bladder cancer diagnosis and treatment","volume":"16","author":"Pignot G","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","article-title":"Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions","volume":"12","author":"Doshi B","year":"2023","journal-title":"Oncogenesis"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman ND","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.chemrestox.2c00153","article-title":"DNA damage and oxidative stress of tobacco smoke condensate in human bladder epithelial cells","volume":"35","author":"Bellamri M","year":"2022","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mc.20860","article-title":"New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer","volume":"51","author":"Gabriel U","year":"2012","journal-title":"Mol Carcinog"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamaoncol.2015.3209","article-title":"Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis","volume":"1","author":"Cumberbatch MGK","year":"2015","journal-title":"JAMA Oncol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13293-025-00715-6","article-title":"Sex differences in bladder cancer: understanding biological and clinical implications","volume":"16","author":"Chaudhary P","year":"2025","journal-title":"Biol Sex Differ"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/stem.1625","article-title":"A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors","volume":"32","author":"Dancik GM","year":"2014","journal-title":"Stem Cells"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs-Part B: prostate and urinary tract tumors","volume":"82","author":"Netto GJ","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.hoc.2014.10.011","article-title":"Nonurothelial bladder cancer and rare variant histologies","volume":"29","author":"Willis D","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10061","key":"ref13","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat AM","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association Of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-a summary of the 2024 guidelines update","volume":"86","author":"Gontero P","year":"2024","journal-title":"Eur Urol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein JM","year":"2024","journal-title":"J Urol"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JU.0000000000002242","article-title":"Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the University of Southern California experience over 3,347 cases","volume":"207","author":"Mitra AP","year":"2022","journal-title":"J Urol"},{"issue":"15","key":"ref17","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.3390\/jcm13154349","article-title":"The prognostic significance of histological subtypes in patients with muscle-invasive bladder cancer: an overview of the current literature","volume":"13","author":"Claps F","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t L","year":"2023","journal-title":"Nat Rev Dis Primer"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.xcrm.2021.100472","article-title":"Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight","volume":"2","author":"Hurst CD","year":"2021","journal-title":"Cell Rep Med"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle invasive bladder cancer","volume":"171","author":"Robertson AG","year":"2017","journal-title":"Cell"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ijms12010334","article-title":"The role of reactive-oxygen-species in microbial persistence and inflammation","volume":"12","author":"Spooner R","year":"2011","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-7-19","article-title":"Role of chronic E. coli infection in the process of bladder cancer- an experimental study","volume":"7","author":"El-Mosalamy H","year":"2012","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","article-title":"Unexpected guests in the tumor microenvironment: microbiome in cancer","volume":"12","author":"Wong-Rolle A","year":"2021","journal-title":"Protein Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcimb.2013.00041","article-title":"The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults","volume":"3","author":"Lewis DA","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"347.e1","DOI":"10.1016\/j.ajog.2015.07.009","article-title":"The female urinary microbiome in urgency urinary incontinence","volume":"213","author":"Pearce MM","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.juro.2017.08.001","article-title":"Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer","volume":"199","author":"Shrestha E","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.eururo.2018.12.043","article-title":"The microbiome and genitourinary cancer: a collaborative review","volume":"75","author":"Markowski MC","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1038\/s41598-018-29054-w","article-title":"The urinary microbiome associated with bladder cancer","volume":"8","author":"Bu\u010devi\u0107 Popovi\u0107 V","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.euo.2020.04.002","article-title":"Sex-specific alterations in the urinary and tissue microbiome in therapy-na\u00efve urothelial bladder cancer patients","volume":"3","author":"Pederzoli F","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1182322","DOI":"10.3389\/fcimb.2023.1182322","article-title":"The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M","volume":"13","author":"Sun JX","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.urolonc.2020.04.014","article-title":"Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study","volume":"38","author":"Chipollini J","year":"2020","journal-title":"Urol Oncol"},{"issue":"16","key":"ref32","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1002\/cam4.2419","article-title":"Dysbiosis signatures of the microbial profile in tissue from bladder cancer","volume":"8","author":"Liu F","year":"2019","journal-title":"Cancer Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder cancer in China","volume":"8","author":"Wu P","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"22198","DOI":"10.1038\/s41598-024-72918-7","article-title":"Intratumoral microbiota as a novel prognostic indicator in bladder cancer","volume":"14","author":"Zhang Y","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.euo.2023.02.004","article-title":"Global meta-analysis of urine microbiome: colonization of polycyclic aromatic hydrocarbon-degrading bacteria among bladder cancer patients","volume":"6","author":"Bukavina L","year":"2023","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"e70012","DOI":"10.1002\/cai2.70012","article-title":"Identification and evaluation of the urinary microbiota associated with bladder cancer","volume":"4","author":"Li N","year":"2025","journal-title":"Cancer Innov"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12885-025-13817-6","article-title":"The role of urinary microbiota in primary and recurrent bladder cancer: insights from a propensity score matching study","volume":"25","author":"Sheng Z","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1038\/s41598-020-67443-2","article-title":"Bladder cancer-related microbiota: examining differences in urine and tissue samples","volume":"10","author":"Mansour B","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan D","year":"2011","journal-title":"Cell"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-5347(17)39897-X","article-title":"Bladder surface glycosaminoglycans: an epithelial permeability barrier","volume":"143","author":"Parsons CL","year":"1990","journal-title":"J Urol"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrurol.2015.292","article-title":"The interplay of extracellular matrix and microbiome in urothelial bladder cancer","volume":"13","author":"Alfano M","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.3390\/ijms21124488","article-title":"Urobiome in gender-related diversities of bladder cancer","volume":"21","author":"Bilski K","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/apm.13097","article-title":"The discovery of bacterial biofilm in patients with muscle invasive bladder cancer","volume":"129","author":"Nadler N","year":"2021","journal-title":"APMIS"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.3390\/ijms22094483","article-title":"The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development","volume":"22","author":"Wigner P","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"1010428317697552","DOI":"10.1177\/1010428317697552","article-title":"Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer","volume":"39","author":"Kumari N","year":"2017","journal-title":"Tumour Biol"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1084\/jem.20090207","article-title":"IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway","volume":"206","author":"Wang L","year":"2009","journal-title":"J Exp Med"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/cancers15030809","article-title":"Urinary Eubacterium sp. CAG:581 promotes non-muscle invasive bladder cancer (NMIBC) development through the ECM1\/MMP9 pathway","volume":"15","author":"Zhang Y","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.20517\/mrr.2023.47","article-title":"The role of microbiota in tumorigenesis, progression and treatment of bladder cancer","volume":"3","author":"Peng Z","year":"2023","journal-title":"Microbiome Res Rep"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/ijms23105319","article-title":"Wnt\/\u03b2-catenin signalling and its cofactor BCL9L have an oncogenic effect in bladder cancer cells","volume":"23","author":"Kotolloshi R","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"9","key":"ref50","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/IAI.00188-08","article-title":"The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis","volume":"76","author":"Cosseau C","year":"2008","journal-title":"Infect Immun"},{"issue":"7203","key":"ref51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani A","year":"2008","journal-title":"Nature"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.tranon.2019.03.003","article-title":"Fusobacterium nucleatum contributes to the carcinogenesis of colorectal cancer by inducing inflammation and suppressing host immunity","volume":"12","author":"Wu J","year":"2019","journal-title":"Transl Oncol"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","article-title":"Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack","volume":"42","author":"Gur C","year":"2015","journal-title":"Immunity"},{"issue":"9","key":"ref54","doi-asserted-by":"crossref","first-page":"e29088","DOI":"10.1002\/jmv.29088","article-title":"Role of human papillomavirus and associated viruses in bladder cancer: an updated review","volume":"95","author":"Yao X","year":"2023","journal-title":"J Med Virol"},{"issue":"10","key":"ref55","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s00436-020-06804-2","article-title":"Parasite-bacteria interrelationship","volume":"119","author":"Ashour DS","year":"2020","journal-title":"Parasitol Res"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/iju.12959","article-title":"Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities","volume":"23","author":"Richards KA","year":"2016","journal-title":"Int J Urol"},{"issue":"3","key":"ref57","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/bjc.2014.601","article-title":"Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study","volume":"112","author":"Vermeulen SH","year":"2015","journal-title":"Br J Cancer"},{"issue":"15","key":"ref58","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/cancers13153649","article-title":"The bladder microbiome is associated with epithelial-mesenchymal transition in muscle invasive urothelial bladder carcinoma","volume":"13","author":"Li WT","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1152\/physiolgenomics.00032.2024","article-title":"Microbiota-induced inflammatory responses in bladder tumors promote epithelial-mesenchymal transition and enhanced immune infiltration","volume":"56","author":"Li Q","year":"2024","journal-title":"Physiol Genomics"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4014\/jmb.2002.02044","article-title":"Fecal microbiota transplantation (FMT) alleviates experimental colitis in mice by gut microbiota regulation","volume":"30","author":"Zhang W","year":"2020","journal-title":"J Microbiol Biotechnol"},{"issue":"5","key":"ref61","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy S","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales A","year":"1976","journal-title":"J Urol"},{"key":"ref63","first-page":"S199","article-title":"The management of BCG failure in non-muscle-invasive bladder cancer: an update","volume":"3(6 Suppl 4)","author":"Zlotta AR","year":"2009","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"ref64","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/curroncol31020079","article-title":"BCG and alternative therapies to BCG therapy for non-muscle-invasive bladder cancer","volume":"31","author":"Lidagoster S","year":"2024","journal-title":"Curr Oncol"},{"issue":"3","key":"ref65","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10654-016-0213-z","article-title":"Is there a link between urinary microbiota and bladder cancer?","volume":"32","author":"Raoult D","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"ref66","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1933719112466306","article-title":"Adhesion of Lactobacillus iners AB-1 to human fibronectin: a key mediator for persistence in the vagina?","volume":"20","author":"McMillan A","year":"2013","journal-title":"Reprod Sci"},{"issue":"6","key":"ref67","doi-asserted-by":"crossref","first-page":"370.e9","DOI":"10.1016\/j.urolonc.2020.12.011","article-title":"Investigating the association between the urinary microbiome and bladder cancer: an exploratory study","volume":"39","author":"Hussein AA","year":"2021","journal-title":"Urol Oncol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.2019.37.7_suppl.423","article-title":"Association of the commensal urinary microbiome with response to Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy in nonmuscle invasive bladder cancer","volume":"37(7_suppl)","author":"Sweis RF","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref69","doi-asserted-by":"crossref","first-page":"22.e13","DOI":"10.1016\/j.urolonc.2023.11.003","article-title":"The bladder microbiota is not significantly altered by intravesical BCG therapy","volume":"42","author":"Heidrich V","year":"2024","journal-title":"Urol Oncol"},{"issue":"9","key":"ref70","doi-asserted-by":"crossref","first-page":"102922","DOI":"10.1016\/j.fjurol.2025.102922","article-title":"Microbiome and immunotherapy in bladder cancer: the missing link","volume":"35","author":"Bourgi A","year":"2025","journal-title":"Fr J Urol"},{"issue":"1","key":"ref71","first-page":"59","article-title":"An update on the effectiveness of probiotics in the prevention and treatment of cancer","volume":"12","author":"Sankarapandian V","year":"2022","journal-title":"Life (Basel)"},{"issue":"1","key":"ref72","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17460913.2024.2414671","article-title":"Microbiome and bladder cancer: the role of probiotics in treatment","volume":"20","author":"Dadgar-Zankbar L","year":"2025","journal-title":"Future Microbiol"},{"issue":"5","key":"ref73","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0022-5347(05)64362-5","article-title":"Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium bovis (bacillus Calmette-Guerin)","volume":"168","author":"Seow SW","year":"2002","journal-title":"J Urol"},{"issue":"6","key":"ref74","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/S0022-5347(05)65625-X","article-title":"Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2","volume":"166","author":"Takahashi T","year":"2001","journal-title":"J Urol"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3390\/diagnostics11122270","article-title":"Supplementation of probiotic Butyricicoccus pullicaecorum mediates anticancer effect on bladder urothelial cells by regulating butyrate-responsive molecular signatures","volume":"11","author":"Wang YC","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"ref76","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12866-021-02407-8","article-title":"Urogenital microbiota: potentially important determinant of PD-L1 expression in male patients with non-muscle invasive bladder cancer","volume":"22","author":"Chen C","year":"2022","journal-title":"BMC Microbiol"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jre.12410","article-title":"Immunologic characteristics of human gingival fibroblasts in response to oral bacteria","volume":"52","author":"Jang JY","year":"2017","journal-title":"J Periodontal Res"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms controlling PD-L1 expression in cancer","volume":"76","author":"Cha JH","year":"2019","journal-title":"Mol Cell"},{"issue":"9","key":"ref79","doi-asserted-by":"crossref","first-page":"e120608","DOI":"10.1172\/jci.insight.120608","article-title":"First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis","volume":"3","author":"Myles IA","year":"2018","journal-title":"JCI Insight"},{"issue":"11","key":"ref80","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1172\/JCI95376","article-title":"Commensal Propionibacterium strain UF1 mitigates intestinal inflammation via Th17 cell regulation","volume":"127","author":"Colliou N","year":"2017","journal-title":"J Clin Invest"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"909799","DOI":"10.3389\/fcimb.2022.909799","article-title":"Gardnerella exposures alter bladder gene expression and augment uropathogenic Escherichia coli urinary tract infection in mice","volume":"12","author":"Gilbert NM","year":"2022","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2026000101404&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:52:07Z","timestamp":1777287127000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2026000101404&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":81,"alternative-id":["S0100-879X2026000101404"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2026e15526","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e15526"}}